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A B S T R A C T
Erythromycin A is a widely used antibiotic produced by Saccharopolyspora erythraea; however, its bio-
synthetic cluster lacks a regulatory gene, limiting the yield enhancement via regulation engineering of
S. erythraea. Herein, six TetR family transcriptional regulators (TFRs) belonging to three genomic context
types were individually inactivated in S. erythraea A226, and one of them, SACE_3446, was proved to play
a negative role in regulating erythromycin biosynthesis. EMSA and qRT-PCR analysis revealed that SACE_3446
covering intact N-terminal DNA binding domain speciﬁcally bound to the promoter regions of erythro-
mycin biosynthetic gene eryAI, the resistant gene ermE and the adjacent gene SACE_3447 (encoding a long-
chain fatty-acid CoA ligase), and repressed their transcription. Furthermore, we explored the interaction
relationships of SACE_3446 and previously identiﬁed TFRs (SACE_3986 and SACE_7301) associated with
erythromycin production. Given demonstrated relatively independent regulation mode of SACE_3446 and
SACE_3986 in erythromycin biosynthesis, we individually and concomitantly inactivated them in an in-
dustrial S. erythraea WB. Compared with WB, the WBΔ3446 and WBΔ3446Δ3986 mutants respectively
displayed 36% and 65% yield enhancement of erythromycin A, following signiﬁcantly elevated transcrip-
tion of eryAI and ermE. When cultured in a 5 L fermentor, erythromycin A of WBΔ3446 andWBΔ3446Δ3986
successively reached 4095 mg/L and 4670 mg/L with 23% and 41% production improvement relative to
WB. The strategy reported here will be useful to improve antibiotics production in other industrial
actinomycete.
© 2016 Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
1. Introduction
Saccharopolyspora erythraea is a Gram-positive actinomycete uti-
lized for the industrial-scale production of a macrolide antibiotic
erythromycin A. Erythromycin and its semi-synthetic derivatives
clarithromycin, azithromycin, dirithromycin, roxithromycin, and
telithromycin arewidely used inmedicine to treat infections caused
by pathogenic Gram-positive bacteria.1 Asworldwide sales of eryth-
romycin and its derivatives reached billions of dollars per year,2
systematic improvements in erythromycin production are of enor-
mous importance. Over the past 60 years, erythromycin production
has been frequently improved by utilizing traditional mutagenesis
and metabolic engineering methodologies.3,4 Genetic modulation
of the overexpression of endogenous tailoring genes eryK (encod-
ing a P450 hydroxylase for C-12 hydroxylation) and eryG (encoding
anO-methyltransferase for C-3’’ O-methylation) or exogenous genes
vhb (encoding a hemoglobin from Vitreoscilla) and metK (encoding
an S-adenosylmethionine synthetase) have enhanced erythromy-
cin production andpurity in industrial S. erythraea strains.5–7 In recent
years, extensive investigations provide insights into the genes in-
volved in erythromycin biosynthesis.4,8 However, unlike many
Streptomyces, S. erythraea lacks a regulatory gene in the erythromycin
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biosynthetic gene cluster, compromising efforts to improve eryth-
romycin production by regulation engineering.
In 2007, completion of the genome sequence of S. erythraea has
offered the opportunity to identify regulators related to erythro-
mycin production and understand the specialized regulatory
mechanism of erythromycin biosynthesis.9 A total of 1118 genes,
corresponding to ~15% of the coding sequences of the S. erythraea
genome, are predicted to be involved in regulation, including mul-
tiple sigma factors and other transcriptional regulators.9 The
developmental regulator BldD (SACE_2077) was found to directly
control the synthesis of erythromycin by binding the promoter
regions of erythromycin biosynthetic genes.10 Recently, we have uti-
lized the improved gSELEX (genomic systematic evolution of ligands
by exponential enrichment) method to capture other target genes
of BldD involved in the erythromycin production and morphogen-
esis in S. erythraea.11 Additionally, a putative regulatory protein
SACE_5599 was also identiﬁed to be positively involved in eryth-
romycin production and morphological differentiation.12
Nevertheless, the regulatory processes governing erythromycin bio-
synthesis in S. erythraea remains obscure.
The TetR family transcriptional regulators (TFRs) are wide-
spread in bacteria, encoding proteins with a conserved helix-turn-
helix (HTH) DNA-binding domain and a C-terminal ligand regulatory
domain.13,14 Members of the TetR family regulate a wide range of
cellular activities, such as antibiotic production, the osmotic stress
response, eﬄux pump production, multidrug resistance, and mod-
ulation of metabolism.13,14 Several TFRs in Streptomyces control the
biosynthesis or export of antibiotics, whether they are encoded
inside the gene cluster for antibiotic biosynthesis or not.15–19 TFRs
are conﬁgured in the Streptomyces genome in three genome con-
texts, grouped according to their orientation relative to neighboring
genes.20 The ﬁrst group is divergently oriented to a neighboring
transcription unit. The second group is likely to be co-transcribed
with an upstream or downstream neighboring gene when sepa-
rated by 35 bp or less. The third group lacks a deﬁned association
of the TFR gene with adjacent genes. Also, a recent review of TRFs
focusing on the nature and diversity of their ligands and related
biochemical processes underscores their inducible and diverse reg-
ulatory systems.21
In silico analysis identiﬁed approximate 100 TFRs encoded by the
S. erythraea genome,9 suggesting an increased complexity to its reg-
ulatory networks. To date, except for two characterized TFRs
(SACE_7040 and SACE_0012) that negatively controlled S. erythraea
morphogenesis,22,23 we recently identiﬁed two additional TFRs
(SACE_3986 and SACE_7301) negatively or positively regulating the
synthesis of erythromycin.24,25 Nonetheless, little is still known about
remaining TFRs encoded by the S. erythraea genome. Therefore, we
herein selected six TFRs with three groups of genome contexts for
gene inactivation to deﬁne potential regulators of erythromycin bio-
synthesis. Through in vivo and in vitro evidences, one of them,
SACE_3446, was conﬁrmed to repress erythromycin biosynthesis,
and its interaction relationship to the other two TFRs (SACE_3986
and SACE_7301) were explored to guide the engineering of an in-
dustrial overproducer for enhancing erythromycin production.
2. Materials and methods
2.1. Bacterial strains, plasmids, and general techniques
The strains and plasmids used in this study are listed in Table 1.
S. erythraea and its derivatives were grown either on solid R3M
medium or in liquid TSB medium with appropriate antibiotics for
recombinant strains at 30 °C.28 Escherichia coli and Bacillus subtilis
strains were cultured in Luria–Bertani (LB) liquid medium or on LB
plates at 37 °C.26 DNA isolation and manipulation in E. coli and
S. erythraea were performed according to previously reported
methods.22,26
2.2. Inactivation of the TetR family regulatory genes in
S. erythraea A226
Six putative TetR family regulatory genes (SACE_0820, SACE_1874,
SACE_2947, SACE_3446, SACE_6589, and SACE_7325) were individ-
ually inactivated in the parental strain A226 as follows: a region
spanning ~1.5 kb of DNA on either side of each regulatory gene was
ampliﬁed from the genome of A226. The upstream and down-
stream homologous fragments were ampliﬁed with their respective
primer pairs P1/P2 and P3/P4 (Table S1), digested with different re-
striction enzymes (Table 1), and inserted into corresponding sites
of pUCTSR (pUC18 derivative containing a 1.36 kb fragment of a
thiostrepton resistance cassette in the BamHI/SmaI sites),22 respec-
tively. Via the homologous recombination of linear DNA fragments,22
those regulatory genes were then each replaced by the thiostrepton
resistance gene (tsr), and themutants were screened by thiostrepton
and further conﬁrmed by PCR analysis with their respective P5 and
P6 primers. Correct disruption mutants were designated as
ΔSACE_0820, ΔSACE_1874, ΔSACE_2947, ΔSACE_3446, ΔSACE_6589, and
ΔSACE_7325.
2.3. Genetic complementation of the ΔSACE_3446 mutant
The SACE_3446 gene (507 bp; GenBank Accession No. NC-
009142; 3,802,179–3,802,685 nt) is a member of the TetR family,
encoding a protein of 168 amino acids with a predicted molecular
mass of 19 kDa. However, the re-annotation of S. erythraea genome
in 2013 indicated that there was a predicted error of initiation codon
position in SACE_3446.29 We searched upstream sequences of the
original SACE_3446, and found three additional initiation codons,
resulting in 4 putative reading frames named SACE_3446A (168 aa,
507 bp), SACE_3446B (182 aa, 549 bp), SACE_3446C (220 aa, 663 bp),
and SACE_3446D (239 aa, 720 bp).
To complement the ΔSACE_3446 mutant, above four SACE_3446
coding sequences were ampliﬁedwith the primers 3446-P7 to 3446-
P14 (Table S1) from the genomic DNA of A226. Then, the PCR
products were cloned into the corresponding sites of pIB139,27 suc-
cessively generating pIB139-3446A, pIB139-3446B, pIB139-3446C,
and pIB139-3446D. Then, these vectors were introduced into the
ΔSACE_3446 mutant by PEG-mediated protoplast transformation,30
the correct transformants (ΔSACE_3446/pIB139-3446A, ΔSACE_3446/
pIB139-3446B, ΔSACE_3446/pIB139-3446C, and ΔSACE_3446/pIB139-
3446D) were selected with apramycin, and they were further
conﬁrmed by PCR analysis.
2.4. Construction of gene deletion/overexpression mutants in the
industrial S. erythraea WB and its derivatives
In accord with above procedures, SACE_3446 was also inacti-
vated in WB strain, generating the WBΔ3446 mutant. To further
knock out SACE_3986 in WBΔ3446, we ﬁrst ampliﬁed the neomy-
cin resistant gene (neo) from SupCos131 using the primers Neo-F/
Neo-R (Table S1), digested with KpnI/BglII, and replaced the tsr gene
of pUCTSRΔ3986,24 generating the pUCNEOΔ3986 plasmid. Like-
wise, through the homologous recombination of linear DNA
fragments, SACE_3986 was replaced by the neo gene, and the mutant
WBΔ3446Δ3986 with sensitivities to thiostrepton and kanamycin
was obtained. Moreover, pSET152 carrying three extra copies of
SACE_7301 under the control of PermE* was transferred into
WBΔ3446Δ3986 to yield WBΔ3446Δ3986/3 × 7301.
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2.5. Fermentation and erythromycin assay
Flask Fermentation of A226,WB and their derivativeswere done
as previously described.25 For bioassay-based erythromycin anal-
ysis, 5 μL above fermentation supernatants were added to LB agar
plates, which were sprayed with an overnight culture of B. subtilis
PUB110. The plates were incubated at 37 °C for 12 h, and the eryth-
romycin productionwas estimated by detecting andmeasuring the
growth-inhibition zones. Fed-batch cultures of WB, WBΔ3446 and
WBΔ3446Δ3986wereperformed in a 5-L fermentor (Baoxing, Shang-
hai, China). Samples (50mL)were taken every 24 h anderythromycin
A was extracted from above cultures in terms of previous reported
method.25HPLCanalysiswas carriedout onAgilent 1260HPLC system
equippedwith anAgilent Extend-C18 column (5 μm; 250 × 4.6mm),
which was equilibrated with 40% solution A (acetonitrile, chro-
matographic grade) and 60% solution B (potassium dihydrogen
phosphate, 0.032 mol/L, pH 6.8). An isocratic program was carried
out at a ﬂow rate of 1.0 mL/min at 29 °C usingUVdetector at 210 nm.
2.6. Quantitative real-time PCR (qRT-PCR)
The relative transcriptional levels of eryAI, ermE, SACE_3447, and
three TetR family regulatory genes (SACE_3446, SACE3986 and
SACE_7301) were determined by qRT-PCR. Speciﬁc primers were de-
signed as listed in Table S1. Total RNA was extracted from A226 and
its derivatives after 2 and 4 days of growth on R5 agar medium.32
As forWB and its derivatives, total RNAwas isolated when they were
cultured for the 4 days. Isolated RNA was treated with DNase I (MBI
Fermentas), and reverse transcription was achieved using a cDNA
synthesis kit (MBI Fermentas). qRT-PCR reactions were performed
on the Applied Biosystems Step-One Plus system with Maxima™
SYBR Green/ROX qPCR Master Mix (MBI Fermentas). The hrdB gene
encoding the major sigma factor in S. erythraea was used as an in-
ternal control, and relative quantiﬁcation was evaluated using the
comparative cycle threshold (CT) method.33
2.7. Expression and puriﬁcation of recombinant SACE_3446 in E. coli
Based on re-annotation of S. erythraea genome,29 three addi-
tional initiation codons within upstream sequences of SACE_3446
were detected, thereby generating 4 putative SACE_3446 coding se-
quences (SACE_3446A, SACE_3446B, SACE_3446C, and SACE_3446D).
Using the genomic DNA of S. erythraea A226 as a template, we am-
pliﬁed these DNA fragments by PCR with the primers 3446-P17
to 3446-P24 (Table S1). Then, the PCR products were cloned into
the NdeI and XbaI sites of pET28a to acquire pET28a-3446A,
Table 1
Bacterial strains and plasmids used in this study.
Strains and plasmids Description Reference
E. coli
DH5α F recA lacZM15 26
BL21 (DE3) F−ompThsdSB(rB− mB−) dcmgalλ(DE3) Novagen
S. erythraea
A226 CGMCC 8279, an erythromycin low producer China Pharmaceutical Culture Collection
ΔSACE_0820 A226 derivative with SACE_0820 deleted This study
ΔSACE_1874 A226 derivative with SACE_1874 deleted This study
ΔSACE_2947 A226 derivative with SACE_2947 deleted This study
ΔSACE_6589 A226 derivative with SACE_6589 deleted This study
ΔSACE_7325 A226 derivative with SACE_7325 deleted This study
ΔSACE_3446 A226 derivative with SACE_3446 deleted This study
ΔSACE_3446/pIB1393446A ΔSACE_3446 carrying pIB1393446A This study
ΔSACE_3446/pIB1393446B ΔSACE_3446 carrying pIB1393446B This study
ΔSACE_3446/pIB1393446C ΔSACE_3446 carrying pIB1393446C This study
ΔSACE_3446/pIB1393446D ΔSACE_3446 carrying pIB1393446D This study
WB CGMCC 8280, an erythromycin industrial overproducer Anhui Wanbei Pharmaceutical Co., Ltd.
WBΔ3446 WB derivative with SACE_3446 deleted This study
WBΔ3446Δ3986 WB derivative with SACE_3446/SACE_3986 deleted This study
WBΔ3446Δ3986/3 × 7301 WBΔ3446Δ3986 derivative carrying pSET152-3 × 7301 This study
Plasmids
pUCTSR pUC18 derivative containing a 1.36-kb fragment of a
thiostrepton resistance gene in BamHI/SmaI sites
22
pUCTSRΔ3446 pUCTSR derivative containing two 1.5-kb fragments, the
upstream and downstream regions of SACE_3446
This study
pUCNEO pUC18 derivative containing a 0.79-kb fragment of a
neomycin resistance gene in BamHI/SmaI sites
This study
pUCTSRΔ3986 pUCTSR derivative containing two 1.5-kb fragments, the
upstream and downstream regions of SACE_3986
24
pUCNEOΔ3986 pUCTSRΔ3986 derivative with tsr replaced by neo This study
pSET152-3 × 7301 pSET152 carrying three extra copies of SACE_7301 under
the control of PermE*
25
pIB139 E. coli – S. erythraea integrative shuttle vector containing
a strong constitutive ermE* promoter
27
pIB1393446A pIB139 carrying an extra SACE_3446A for the gene
complementation
This study
pIB1393446B pIB139 carrying an extra SACE_3446B for the gene
complementation
This study
pIB1393446C pIB139 carrying an extra SACE_3446C for the gene
complementation
This study
pIB1393446D pIB139 carrying an extra SACE_3446D for the gene
complementation
This study
pET28a T7 promoter, His-tag, kan Novagen
pET28a-3446A pET28a-derived plasmid carrying SACE_3446A This study
pET28a-3446B pET28a-derived plasmid carrying SACE_3446B This study
pET28a-3446C pET28a-derived plasmid carrying SACE_3446C This study
pET28a-3446D pET28a-derived plasmid carrying SACE_3446D This study
The symbol * represents changed version of original ermE promoter.
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pET28a-3446B, pET28a-3446C, and pET28a-3446D, respectively.
Those plasmids were transformed into E. coli BL21 (DE3) for protein
production. Gene expression was induced with 0.5 mM IPTG for 5 h
at 30 °C. Cells were harvested and lysed by sonication treatment.
Puriﬁcation of His6-SACE_3446 fusion protein was performed by Ni-
NTA Sepharose chromatography.34 The concentration of puriﬁed
fusion protein was analyzed by BCA assays, and its purity was judged
by SDS-PAGE analysis.
2.8. Electrophoretic mobility shift assays (EMSAs)
DNA fragments harboring eryAI, ermE, or SACE_3447 promoter
regions were independently obtained by PCR ampliﬁcationwith their
respective primers (Table S1), and 5′-end labeled with
6-carboxyﬂuorescein (6-FAM). Those labeled DNA fragments were
successively mixed with above puriﬁed His6-tagged SACE_3446 pro-
teins. The binding reaction system contained 10 mM Tris (pH 7.5),
5 mM MgCl2, 50 mM EDTA, 60 mM KCl, 10 mM DTT, 10% glycerol,
150 ng labeled probe, and 0.2–1.4 μM puriﬁed protein. 7.5 μg un-
labeled DNA fragments or 7.5 μg poly dIdC were respectively added
into the reaction system for competitive assays. After incubation on
ice for 10 min, the reactants were run on an 8% TBE polyacryl-
amide gel (Bio-Rad) buffered in 0.5 X TBE at 30 mA for 1 h.
3. Results
3.1. Genomic and bioinformatics analysis of TFRs in S. erythraea
Actinomycete chromosomes are mostly linear, with a con-
served ‘core’ region that contains most of the essential genes, and
variable ‘non-core’ regions at both ends, primarily including non-
essential species-speciﬁc genes.35 The 8.2-Mb circular chromosome
of S. erythraea has a ‘core’ region containing two parts (6.3–8.2 Mb
and 0–2.5 Mb) around the origin of replication oriC. The remain-
ing region from 2.5 to 6.3 Mb is deﬁned as the ‘non-core’ region.
By combining protein BLAST analysis with the consensus se-
quence for Pfam PF00440 (TetR_N) and the genome annotation of
S. erythraea,9,20 we identiﬁed 97 genes encoding putative TFRs, which
were distributed evenly over its chromosomes with a slight en-
richment in the non-core (3.8Mb, 12.6 TFRs/Mb), relative to the core
Fig. 1. Inactivation of SACE_3446 in S. erythraea A226. (a) Schematic deletion of SACE_3446 by linearized fragment homologous recombination in A226. (b) PCR conﬁrma-
tion of the SACE_3446 deletion mutant by the primers 3446-P5/3446-P6. A 750-bp PCR-ampliﬁed band was observed in A226, while a 1603-bp band was detected in the
ΔSACE_3446 mutant. (c) Inhibition tests of deletion mutants of six TetR family regulators against B. subtilis. (d) Comparison of the erythromycin titer estimated by scoring
the growth-inhibition zones. (e) Time course of erythromycin A yield in A226 and ΔSACE_3446 by HPLC analysis. The mean values of at least three replicates are shown,
with the standard deviation indicated by error bars. (f) Erythromycin A production in ΔSACE_3446 expressing SACE_3446 from four different initiation codons by HPLC anal-
ysis. (g) Growth curves of A226 and ΔSACE_3446. The two strains were cultured in R5 liquid medium, and their dry weights of mycelia (DWM)were measured. (h) Morphological
differentiation of S. erythraea A226 and its derivatives. All strains were grown on R3M agar medium at 30 °C for 36 and 48 h. 1, A226; 2, ΔbldD; and 3, ΔSACE_3446.
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regions (4.4 Mb, 11.1 TFRs/Mb). Based on the genome context anal-
ysis of individual TFR,20 69% (67/97), 14% (14/97), and 17% (16/97)
of TFRs are in the ﬁrst, second, and third groups, respectively. Thus,
the orientation of most TFRs in S. erythraea is divergent from their
neighboring genes. Herein, we randomly chose twomembers of each
group (SACE_2947 and SACE_3446, group one; SACE_6589 and
SACE_7325, group two; and SACE_0820 and SACE_1874, group three)
to search for candidate TFRs related to erythromycin biosynthesis
in S. erythraea.
3.2. SACE_3446 negatively regulates erythromycin biosynthesis
Through the homologous recombination of linearized fragments,22
aforementioned six genes of TetR family were individually inacti-
vated in S. erythraea A226, and the desired mutants were obtained
by thiostrepton resistant screening and PCR conﬁrmation (Fig. 1a–b,
with the currently studied SACE_3446 as an example). By fermen-
tation and bioassay analysis, we demonstrated that the ΔSACE_2947,
ΔSACE_0820, and ΔSACE_3446 mutants created a larger inhibition
zone against B. subtilis PUB110 than their parental strain A226.
Among these mutants, ΔSACE_3446 presented the highest inhibi-
tion activity (Fig. 1c–d) and was selected for further investigation.
To conﬁrm its negative effect on erythromycin production, the
ΔSACE_3446 mutant and its parental strain A226 were cultivated in
the liquid R5medium for 6 days, and extracts of those cultures were
quantiﬁed by HPLC analysis. Compared with A226 (52.8 mg/L),
ΔSACE_3446 displayed an increased erythromycin A yield by 49.4%
(78.9 mg/L) (Fig. 1e). Intriguingly, when ΔSACE_3446 was comple-
mented with 4 predicted SACE_3446 genes under the control of
PermE* promoter, erythromycin A yield of these desired mutants
all recovered to nearly original levels (Fig. 1f). We further com-
pared the mycelium dry weight of A226 and ΔSACE_3446 cultured
in the liquid R5 medium, and found that the two strains had com-
parable growth rates and cell densities (Fig. 1g), demonstrating that
elevated erythromycin yield in ΔSACE_3446 was not caused by en-
hancement of cell growth. Also, when cultured on R3M agarmedium,
ΔSACE_3446 was identical to A226 in the rate of aerial mycelium
formation, whereas ΔbldD introduced the expected defect of aerial
hyphae (Fig. 1h). Taken together, these ﬁndings indicate that
SACE_3446 exclusively acts as a repressor to regulate the synthe-
sis of erythromycin in S. erythraea.
3.3. SACE_3446 speciﬁcally binds to the promoter regions of eryAI,
ermE, and SACE_3447
To determine whether SACE_3446 play a direct role in regulat-
ing erythromycin biosynthesis, EMSAs were performed with the
promoter regions of erythromycin biosynthetic gene eryAI and the
resistant gene ermE. During above 4 putative SACE_3446, only 2
longer protein-coding sequences (SACE_3446C and SACE_3446D)
completely covered the DNA-binding domain (Fig. 2a). Based on the
pET28a vector, we successfully expressed SACE_3446B, SACE _3446C,
and SACE _3446D in E. coli BL21 (DE3); however, it failed to express
SACE _3446A, although we performed the experiments with various
conditions. In light of the similar phenomenon reported previously,12
the shortest SACE_3446A might be rapidly degraded during its ex-
pression process.
Then, the 3 recombinant His6-SACE_3446 proteins were puri-
ﬁed from E. coli BL21 (DE3) harboring pET28a-3446B, pET28a-
3446C and pET28a-3446D (Fig. 2b). The results from EMSAs showed
that His6-SACE_3446C and His6-SACE_3446D, but not His6-
SACE_3446B, could bind to the promoter regions of eryAI and ermE
(Fig. 2c). To examine the binding speciﬁcity, EMSAs with an excess
of unlabeled speciﬁc or nonspeciﬁc competitor DNA (poly dIdC) were
performed (Fig. 2c), demonstrating that puriﬁed His6-SACE_3446C
and His6-SACE_3446D bound speciﬁcally to eryAI and ermE pro-
moter regions. In addition, given SACE_3446 is classiﬁed as the group
I TFR because it shows a divergent orientation to its adjacent gene
Fig. 2. Binding of puriﬁed SACE_3446 proteins to the promoter regions of eryAI, ermE and SACE_3447. (a) Bioinformatics analysis indicating that 3 alternative initiation codons
for SACE_3446, resulting in 4 predicted coding proteins. (b) SDS-PAGE analysis of puriﬁed His6-SACE_3446 proteins. Left lane, 116 KDa protein ladder; right lane, recombi-
nant protein (1, puriﬁed SACE_3446B; 2, puriﬁed SACE_3446C; and 3, puriﬁed SACE_3446D). (c) EMSAs with the promoter regions of eryAI, ermE, and SACE_3447 and 3 His6-
SACE_3446 proteins.
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SACE_3447 (encoding a long-chain fatty-acid CoA ligase); we also
performed EMSAs with the promoter region of SACE_3447. The gel
shift bands were obviously detected when successively adding pu-
riﬁed His6-SACE_3446C and His6-SACE_3446D (Fig. 2c). Consequently,
it was proved that the SACE_3446 protein with entire N-terminal
DNA binding domain could speciﬁcally bind to the promoter regions
of eryAI, ermE, and SACE_3447.
3.4. SACE_3446 represses the transcription of eryAI, ermE, and
SACE_3447
To evaluate the regulatory signiﬁcance of SACE_3446 for its targets
as mentioned above, we chose eryAI, ermE and SACE_3447 for tran-
scriptional comparison between A226 and ΔSACE_3446 grown for
2–4 days by qRT-PCR. In the 2-day growth period, the transcrip-
tions of eryAI, ermE, and SACE_3447 were not remarkably different
among the two strains (Fig. 3a). When grown for 4 days, com-
pared with the wild-type A226, ΔSACE_3446 displayed increased
transcriptional levels of eryAI, ermE and SACE_3447 by 2.1-, 2.6-, and
5.2-fold, respectively, (Fig. 3b). Consequently, those results, togeth-
er with EMSA evidences, indicated that SACE_3446 repressed the
expression of eryAI and ermE, as well as the neighboring gene
SACE_3447 by directly interacting with their promoter regions.
3.5. Interaction relationships of three TFRs associated with
erythromycin biosynthesis
We previously identiﬁed and dissected the two TFRs, SACE_3986
and SACE_7301, involved in the erythromycin production, and
SACE_3986 inactivation or SACE_7301 overexpression in the indus-
trial S. erythraea WB resulted in the yield improvement.24,25 Herein,
we examined their interaction relationship to SACE_3446 via qRT-PCR
and EMSA analysis. Compared with wild-type A226, ΔSACE_3446
did not exhibit differential expression of SACE_7301 and SACE_3986
(Fig. 4a), the same pattern as SACE_3446 and SACE_7301 in
ΔSACE_3986 (Fig. 4b). Intriguingly, the transcriptions of SACE_3446
and SACE_3986 in ΔSACE_7301 were both signiﬁcantly increased rel-
ative to that in A226 (Fig. 4c). SACE_7301 did not bind to the
upstream regions of SACE_3446 and SACE_3986 (data not show).
These data suggested that the regulation by SACE_3446 and
SACE_3986 is relatively independent; however, SACE_7301 played
an indirect role in negatively regulating the expression of SACE_3446
and SACE_3986.
Fig. 3. Effects of SACE_3446 disruption on the transcription of eryAI, ermE, and SACE_3447. qRT-PCR was used to quantify the amounts of transcripts produced by A226 and
ΔSACE_3446 cultured for 2 days (a) and 4 days (b). The mean values of three independent experiments are shown, with the standard deviation indicated by error bars.
Fig. 4. SACE_7301 indirectly regulated the transcriptions of SACE_3446 and SACE_3986.
Gene transcription was compared between A226 and deletion mutants of three TetR
family genes (SACE_3446, SACE_3986, and SACE_7301) cultured for 4 days via qRT-
PCR assay. (a) Effects of SACE_3446 disruption on the transcriptions of SACE_3986
and SACE_7301. (b) Effects of SACE_3986 disruption on the transcriptions of
SACE_3446 and SACE_7301. (c) Effects of SACE_7301 disruption on the transcrip-
tions of SACE_3446 and SACE_3986. Themean values of three independent experiments
are shown, with the standard deviation indicated by error bars.
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3.6. Double deletion of SACE_3446/SACE_3986 in the industrial
strain WB enhances erythromycin yield
To examine its practical application, SACE_3446 was likewise in-
activated in the high-yield S. erythraea WB strain, generating the
WBΔ3446 mutant. When cultured in a ﬂask with the liquid indus-
trial medium for 6 days,WBΔ3446 displayed enhanced erythromycin
A production by 36% over WB (Fig. 5a). As SACE_3446 and the other
identiﬁed TFR (SACE_3986) played the independent role in the neg-
ative regulation of erythromycin biosynthesis,we further inactivated
SACE_3986 in WBΔ3446. As expectedly, erythromycin A produc-
tion of theWBΔ3446Δ3986 doublemutant was 1033mg/L, separately
approaching 21% and 19% enhancement over WBΔ3446 (851 mg/
L) and WBΔ3986 (871 mg/L), especially the highest 65 % in
comparison to WB (628 mg/L) (Fig. 5a). A previous study demon-
strated that overexpression of SACE_7301 inWB dramatically elevated
its erythromycin A yield,25 thereby we expressed SACE_7301 with
3 extra copies under the control of PermE* in the WBΔ3446Δ3986,
to yieldWBΔ3446–3986/3 × 7301. Interestingly, erythromycin A yield
in WBΔ3446–3986/3 × 7301 was dramatically decreased relative to
that in WBΔ3446–3986, but a little higher than that in WB (Fig. 5a).
Furthermore, we compared the transcriptional levels of eryAI and
ermE among WB, WBΔ3446Δ3986 and WBΔ3446–3986/3 × 7301 by
qRT-PCR assay. Compared toWB, the transcription of eryAI and ermE
in WBΔ3446Δ3986 was up-regulated by 3.7- and 1.9-fold; however,
that in Δ3446Δ3986/3 × 7301 slightly increased by nearly 1.5-fold
(Fig. 5b), in which the transcriptional pattern was well correlated
with the trend of yield alteration.
In addition, we tested the engineered strainsWBΔSACE_3446 and
WBΔ3446Δ3986 in a larger scale fermentation. The time course of
erythromycin fermentation in those strains at a 5-L fermentor is
shown in Fig. 5c. At the end of fermentation, the yield of erythro-
mycin A in WBΔ3446 reached 4095 mg/L, an approximately 23%
production increment over its original productivity (3322 mg/L)
(Fig. 5c). WBΔ3446Δ3986 (4670 mg/L) exhibited the highest yield,
which was 14% and 41% higher than WBΔ3446 and WB, respec-
tively (Fig. 5c).
4. Discussion
In previous studies, we have identiﬁed two TFRs, SACE_3986 and
SACE_7301, to successively repress and induce erythromycin
production;24,25 however, knowledge of the members of this family
associated with erythromycin biosynthesis in S. erythraea re-
mained limited. Herein, through genome context analysis, we
systematically analyzed the TFRs in S. erythraea, and found that most
of them are classiﬁed as the group I TFR, consistent with TFRs anal-
ysis in three Streptomyces.20 During the type I TFRs, SACE_3446 was
proved to repress erythromycin biosynthesis, the same as identi-
ﬁed TFR SACE_3986.24
In terms of the re-annotation of S. erythraea genome in 2013,29
three alternative initiation codons for SACE_3446 were detected, but
the shorter SACE_3446A and SACE_3446B did not cover intact
N-terminal DNA binding domain. To our surprise, the genetic comple-
mentation of SACE_3446 with any of above four coding proteins in
ΔSACE_3446 all restored original levels of erythromycin A yield. Ac-
tually, in the construction process of SACE_3446-disrupted mutant,
the DNA-binding core domain was not deleted. Thus, it might fuse
with SACE_3446A or SACE_3446B for full activities.
Fig. 5. Effects of SACE_3446/SACE_3986 deletion and SACE_7301 overexpression on erythromycin production and gene transcription in the industrial strain WB. (a) Eryth-
romycin A yield of WB and its derivatives cultured in ﬂasks for 6 days. The mean values of at least three replicates are shown, with the standard deviation indicated by
error bars. (b) qRT-PCR analysis of eryAI and ermE in WB, WBΔ3446Δ3986, and WBΔ3446Δ3986/3 × 7301 cultured for 4 days. (c) Time course of erythromycin A production
of WB, WBΔ3446 and WBΔ3446Δ3986 in a 5-L fermentor. One of the representative datasets is shown.
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Similar to SACE_3986,24 we proved that SACE_3446 bound spe-
ciﬁcally to promoter region of the adjacent gene SACE_3447, and
reduced its transcription. Differently, it repressed the transcrip-
tion of eryAI and ermE by interacting with their promoters, while
SACE_7301 acted as a positive regulator directly modulating the syn-
thesis of erythromycin.10,25 Furthermore, we assessed the interaction
relationships of three aforementioned TFRs and demonstrated that
there was no cross-talk regulation between SACE_3446 and
SACE_3986, while SACE_7301 indirectly repressed the expression
of the other two TFRs.
To evaluate the potential application of above interaction rela-
tionships, an industrial S. erythraea WB strain was engineered via
deletion or overexpression of the three TFRs. Our data conﬁrmed
that individual and combined deletion of SACE_3446 and SACE_3986
had stepwise enhancement in erythromycin A yield, probably owing
to their independent regulatory roles in erythromycin biosynthe-
sis. However, when SACE_7301 was expressed with 3 extra copies
under PermE* in theWBΔ3446Δ3986, a reduced production and cor-
responding decreased transcriptions of eryAI and ermEwere detected
in WBΔ3446–3986/3 × 7301. To be speciﬁc, in WB, SACE_7301 di-
rectly activated the expression of eryAI and ermE, whereas it
repressed their transcriptions when SACE_3446 and SACE_3986 were
absent. As SACE_7301 also exerted indirect transcriptional repres-
sion of above two TFRs, we proposed its regulatory pattern was
dependent on SACE_3986 and SACE_3446. The regulation mecha-
nism seems to be more complicated than previously expected, and
remains to be elucidated. Capturing of more targets of these TFRs
with the improved gSELEX method11 are being performed to con-
struct the global regulatory network for uncovering aforementioned
mysteries, and will be contribute to systematically improve the pro-
ductivity of erythromycin in S. erythraea.
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